Status:
UNKNOWN
The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay May Improve ICSI Outcome.
Lead Sponsor:
Meir Medical Center
Collaborating Sponsors:
Assuta Medical Center
Tel Aviv University
Conditions:
Fertility Issues
Eligibility:
FEMALE
18-38 years
Phase:
NA
Brief Summary
In this prospective randomized sibling-oocytes blinded study, investigators examine the combination of two sperm selection methods that logically seem to complete each other, and potentially may impro...
Eligibility Criteria
Inclusion
- females ages 38 or younger retrieval of at least 5 mature oocytes and fresh ejaculate samples
Exclusion
- frozen embryos surgically extracted sperm preparations embryo-biopsy cycles
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT06156722
Start Date
March 1 2019
End Date
February 1 2024
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel